Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two BBC exposé pharmacists to rejoin GPhC register

The regulator has deemed Bita Faizollahi, registration number 2047300, and Ghanshyam Kanji Hirani, registration number 2026341, fit to practise following rehabilitation measures

Two pharmacists who were caught on film supplying antibiotics without a prescription are due to rejoin the professional register, C+D has learned.

Bita Faizollahi, registration number 2047300, and Ghanshyam Kanji Hirani, registration number 2026341, can both return to practice in August following 12-month suspensions by the General Pharmaceutical Council (GPhC) for illegal medicine supplies made during a BBC investigation.

The investigation by BBC Inside Out, which aired in December 2012, showed patients obtaining prescription-only antibiotics without a prescription from Ms Faizollahi's and Mr Hirani’s pharmacies.

Footage from the BBC showed Mr Hirani “casually” handing a packet of amoxicillin to an undercover reporter “as if it was nothing more than a bar of chocolate”, the GPhC's fitness-to-practise (FTP) committee heard at his review hearing on June 29 this year.

But the GPhC said it had received “a great deal of information” on how Mr Hirani had “set about addressing his rehabilitation” by initiating a programme of mentorship and completing a return-to-practice course. The regulator was satisfied that the measures had resulted in “genuine learning”. It also felt Mr Hirani had “reflected deeply” on his conduct and was “full of shame”.

The GPhC deemed the risk that Mr Hirani would repeat his mistake “acceptably low”, and ruled him fit to practise. His suspension will expire on August 4.

The BBC investigation also showed Ms Faizollahi supervising the sale of amoxicillin without a prescription, the GPhC heard at her review hearing on July 13. A BBC undercover reporter indicated that he wished to buy the 500mg strength of the antibiotic, which was handed to him by the counter assistant after Ms Faizollahi took a packet off the shelf.

Despite Ms Faizollahi continuing to have the “greatest difficulty” in admitting her full misconduct to the GPhC, the regulator said she had “reflected long and hard” on her actions and had “genuinely acknowledged to herself and her colleagues the significance of what she did”.

The FTP committee stressed it had “no doubt” that Ms Faizollahi was a good pharmacist and was confident she would not repeat her misconduct. It ruled her fit to practise and her suspension will expire on August 12.

One other pharmacist remains suspended as a result of the BBC investigation and two have been struck off.

Read the full determination for Ms Faizollahi here.

 

The case factfiles

Case 1

Name: Ghanshyam Kanji Hirani

Registration number: 2026341

Length of suspension: 12 months

Misconduct: Sold a packet of amoxicillin without a prescription. Could not offer an explanation for the incident because he said he could not remember his motivation.

Aggravating factors: Still unable to explain his actions on the day of the BBC footage. Fitness to practise was previously called into question in 1992 for providing the morning-after pill without a prescription to a person “who wanted them for the girlfriend of a married man he knew”.

Mitigating factors: Had meetings with a mentor and undertook a “carefully planned” programme of CPD including workshops, seminars and online learning, as well as attending a return-to-practice course

What the GPhC's FTP committee said: “We are satisfied that Mr Hirani has demonstrated very fully that he does indeed appreciate the seriousness of his actions and its consequence for risk to patient safety, as well as the impact of his behaviour upon public confidence.”

 

Case 2

Name: Bita Faizollahi

Registration number: 2047300

Length of suspension: 12 months

Misconduct: Supervising the sale of 500mg amoxicillin without a prescription. She denied being aware of the supply, which was made by the counter assistant on duty.

Aggravating factors: Continues to have “the greatest difficulty” in admitting to the GPhC the full extent of her actions on the day of the incident.

Mitigating factors: Admitted the misconduct to herself and her colleagues, receiving their “unequivocal support”. Undertook CPD exercises, including one specifically on antibiotics, and had several meetings with a mentor.

What the GPhC's FTP committee said: “It is clear to us that Ms Faizollahi has the unequivocal support of a number of people with knowledge of her work and her approach to her profession... We would urge Ms Faizollahi to continue to use the help of her mentor and her superintendent to recover her confidence as she returns to practice.”


    What do you make of the rulings?

    We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

    Related Content

    Topics

             
    Pharmacist Manager
    Barnsley
    £30 per hour

    Apply Now
    Latest News & Analysis
    See All
    UsernamePublicRestriction

    Register

    CD007571

    Ask The Analyst

    Please Note: You can also Click below Link for Ask the Analyst
    Ask The Analyst

    Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

    All fields are required.

    Please make sure all fields are completed.

    Please make sure you have filled out all fields

    Please make sure you have filled out all fields

    Please enter a valid e-mail address

    Please enter a valid Phone Number

    Ask your question to our analysts

    Cancel